Mohammad Ali

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Dynamic retinal vessel response to flicker in obesity: A methodological approach

Konstantin Kotliar, Ines Lanzl, Arno Schmidt‐Trucksäss et al. · Microvascular Research · 2010 · 85 citations

Obesity, Metabolic Syndrome, Retina +11

Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function†

Eran Elinav, Mohammad Ali, Rafi Bruck et al. · Hepatology · 2008 · 73 citations

Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report

Jee Su Suh, Laura M. Fiori, Mohammad Ali et al. · Psychoneuroendocrinology · 2021 · 15 citations · Full text